Name:  ___         Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Evaluation of gastric restrictive surgery, will undergo lap 
sleeve gastrectomy 
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy 

 
History of Present Illness:
___ is a ___ female referred for the
evaluation of gastric restrictive surgery. She has been seen and
evaluated in our ___ clinic on ___. 

___ has class II severe obesity with weight of 210 pounds as
of ___ with her initial screening weight of 221.2 pounds on
___, height 62.5 inches and BMI of 39.4.  

Comorbidities referable to obesity include pre-diabetes, mild
reflux, OA, HLD, and fatty liver.

___ previous weight loss endeavors include Weight Watchers,
Slim-Fast, over-the-counter dietary supplements Dexatrim and
Metabolife as well as working with a nutritionist/RD at the
___.  

Ms. ___ highest weight was 225.1 pounds on
___.  She stated that she has been struggling with weight 
for
the past ___ years and cites as factors contributing to her 
excess
weight watch portions, late-night eating, emotional eating and
lack of exercise. 

Present exercise includes walking for 30 minutes 4 times a week.

She denied history of eating disorders. She does have reactive
and situational depression but is not currently being seen by a
therapist nor has she been hospitalized for mental health issues
and she is not on any psychotropic medications.

She denies fevers, chills, nausea, vomiting, diarrhea,
constipation. 
 
Past Medical History:
PMH:
1)  borderline type 2 diabetes with hemoglobin A1c of 6.0%
2)  history of hyperlipidemia
3)  osteoarthritis of lower extremity joints with knee pain
4)  hepatic steatosis by ultrasound study
5)  vitamin D deficiency
6)  mild gastroesophageal reflux by upper GI series
 
Social History:
___
Family History:
Family:
father deceased age ___ with pulmonary disease and alcohol abuse;
mother living with osteoporosis and arthritis; aunt living with
history of breast CA.
 
Physical Exam:
VS: Temp: 98.6 PO BP: 150/87 L Lying HR: 76 RR: 18 O2 sat: 96% 
O2
delivery: Ra 
GEN: A&Ox3, NAD, resting comfortably 
HEENT: NCAT, EOMI, sclera anicteric
CV: RRR
PULM: no respiratory distress
ABD: abd soft, ND, non-tender, incision gauze c/d/I
EXT: warm, well-perfused, no edema 
PSYCH: normal insight, memory, and mood
WOUND(S): Incision c/d/i
 
Pertinent Results:
___ 05:30AM Hgb-9.5* Hct-29.2* 
___ 05:25AM Hgb-9.8* Hct-29.5*
___ 01:50PM Hgb-10.2* Hct-29.8* 
___ 05:08AM Hct-29.7*
___ 09:58AM Hct-37.9
 
Brief Hospital Course:
The patient presented to pre-op on ___. Patient was 
evaluated by anaesthesia.  
The patient was taken to the operating room for a laparoscopic 
sleeve gastrectomy for obesity. There were no adverse events in 
the operating room; please see the operative note for details. 
Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation. 
 
 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
crushed oral pain medication once tolerating a stage 3 diet. She 
did not require any pain medication on the day of discharge. 
 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  
 Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  
 GI/GU/FEN: The patient was initially kept NPO. Afterwards, the 
patient was started on a stage 1 bariatric diet, which the 
patient tolerated well. Subsequently, the patient was advanced 
to stage 2, and then stage 3 diet. She had issues with nausea 
and small volume emesis and as such her diet was slowed down 
slightly. She also received Zofran and Phenergan to help with 
her nausea. She was eventually advanced to a normal stage 3 diet 
which the patient was tolerating on day of discharge without any 
discharge. 
 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none.  
 HEME: The patient's blood counts were closely watched for signs 
of bleeding. She had a HCT drop from 37.9 on POD0 to 29.7 on 
POD1. Repeat HCT in the afternoon on POD1 was stable at 29.8. 
Repeat HCT on POD2 was stable at 29.8. Repeat HCT on POD3 was 
stable at 29.2. Given her stable HCT there was no concern for 
active bleeding.   
 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay, but HSQ was held after 
HCT drop on POD1. Patient was encouraged to get up and ambulate 
as early as possible and she actively walked several times a day 
throughout her stay. 
 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet without nausea/vomiting, ambulating, 
voiding without assistance, and pain was well controlled. The 
patient received discharge teaching and follow-up instructions 
with understanding verbalized and agreement with the discharge 
plan.  

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. erythromycin 5 mg/gram (0.5 %) ophthalmic (eye) ASDIR 
2. Loratadine 10 mg PO ASDIR 
3. Vitamin D ___ UNIT PO DAILY 

 
Discharge Medications:
1.  Famotidine 20 mg PO BID 
RX *famotidine 40 mg/5 mL (8 mg/mL) 2.5 mL by mouth twice a day 
Refills:*0 
2.  erythromycin 5 mg/gram (0.5 %) ophthalmic (eye) ASDIR  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Pt is a ___ female referred for the evaluation of 
gastric restrictive surgery, s/p lap sleeve gastrectomy 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Discharge Instructions: Please call your surgeon or return to 
the Emergency Department if you develop a fever greater than 101 
F, shaking chills, chest pain, difficulty breathing, pain with 
breathing, cough, a rapid heartbeat, dizziness, severe abdominal 
pain, pain unrelieved by your pain medication, a change in the 
nature or severity of your pain, severe nausea, vomiting, 
abdominal bloating, severe diarrhea, inability to eat or drink, 
foul smelling or colorful drainage from your incisions, redness, 
swelling from your incisions, or any other symptoms which are 
concerning to you.

Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 

Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  
Some of the new medications you will be taking include:
1.  Pain medication: You may also take liquid acetaminophen 
(Tylenol) for pain management; do not exceed 4000 mg per 24 hour 
period.
2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.
3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.
4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.
5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.

Activity:
You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.

Wound Care:
You may remove any remaining gauze from over your incisions.  
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.   
You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry.  Avoid tub baths or 
swimming until cleared by your surgeon. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites. 
Avoid direct sun exposure to the incision area for up to 24 
months.
Do not use any ointments on the incision unless you were told 
otherwise.

 
Followup Instructions:
___